Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intratumoral therapies and in-situ vaccination for melanoma. | Hum Vaccin Immunother | 2022 | 35559766 | PubTator, text mining | PubMed |
| Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy. | Front Cell Dev Biol | 2022 | 35557952 | PubTator, text mining | PubMed |
| Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy. | BMJ Open | 2022 | 35551087 | PubTator, text mining | PubMed |
| Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging. | Chem Rev | 2022 | 35549242 | PubTator, text mining | PubMed |
| Potential clinical utility of liquid biopsies in ovarian cancer. | Mol Cancer | 2022 | 35545786 | PubTator, text mining | PubMed |
| Circulating tumor cells: A step toward precision medicine in hepatocellular carcinoma. | J Gastroenterol Hepatol | 2022 | 35543075 | PubTator, text mining | PubMed |
| Discovery and Structural Basis of the Selectivity of Potent Cyclic Peptide Inhibitors of MAGE-A4. | J Med Chem | 2022 | 35522528 | PubTator, text mining | PubMed |
| Landscape of helper and regulatory antitumour CD4+ T cells in melanoma. | Nature | 2022 | 35508657 | PubTator, text mining | PubMed |
| Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer. | J Oncol | 2022 | 35505821 | PubTator, text mining | PubMed |
| Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma. | Front Mol Biosci | 2022 | 35495634 | PubTator, text mining | PubMed |
| Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma. | Front Cell Dev Biol | 2022 | 35493068 | PubTator, text mining | PubMed |
| Current Trends in Circulating Biomarkers for Melanoma Detection. | Front Med (Lausanne) | 2022 | 35492361 | PubTator, text mining | PubMed |
| Esophageal squamous cell carcinoma: Integrated bioinformatics analysis for differential gene expression with identification of hub genes and lncRNA. | Biochem Biophys Rep | 2022 | 35479061 | PubTator, text mining | PubMed |
| The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus-related hepatocellular carcinoma. | Int J Cancer | 2022 | 35467769 | PubTator, text mining | PubMed |
| The Importance of Being Presented: Target Validation by Immunopeptidomics for Epitope-Specific Immunotherapies. | Front Immunol | 2022 | 35464395 | PubTator, text mining | PubMed |
| Heterogeneity of the tumor immune microenvironment and its clinical relevance. | Exp Hematol Oncol | 2022 | 35461288 | PubTator, text mining | PubMed |
| AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia. | Int J Mol Sci | 2022 | 35457141 | PubTator, text mining | PubMed |
| Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome. | Int J Mol Sci | 2022 | 35457101 | PubTator, text mining | PubMed |
| Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers. | Pharmaceutics | 2022 | 35456701 | PubTator, text mining | PubMed |
| Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy. | Pharmaceutics | 2022 | 35456655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=28